These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814 [TBL] [Abstract][Full Text] [Related]
73. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis. Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240 [TBL] [Abstract][Full Text] [Related]
74. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis. Korman B Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809 [TBL] [Abstract][Full Text] [Related]
75. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis. Jelaska A; Korn JH Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882 [TBL] [Abstract][Full Text] [Related]
77. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related]